# Yuko Kitagawa

Source: https://onco.cc/people/kitagawa-yuko/  
OnCo record `kitagawa-yuko` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Yuko Kitagawa is a leading oesophageal surgeon in the JCOG network, whose trials define perioperative treatment for oesophageal cancer in Japan.

## Summary

Yuko Kitagawa is Professor of Surgery at Keio University, an oesophageal surgeon and a leader of the oesophageal group within the Japan Clinical Oncology Group. His JCOG trials define perioperative treatment for oesophageal cancer in Japan, including JCOG1109, known as NExT, which established triplet neoadjuvant chemotherapy for locally advanced oesophageal squamous cell carcinoma. His publications include the NExT comparison of neoadjuvant cisplatin plus 5-FU, docetaxel plus cisplatin plus 5-FU, and chemoradiotherapy, a Japanese counterpart to the CROSS approach. His interests are oesophageal cancer surgery, perioperative therapy and sentinel node navigation.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Professor of Surgery, Keio University; oesophageal surgery; JCOG oesophageal group leadership
- Specialisms: Oesophageal cancer surgery; Perioperative therapy; Sentinel node navigation

## Sources

- JCOG: https://jcog.jp/en/
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Kitagawa%20Y%5BAuthor%5D%20esophageal%20JCOG

## Connected records

- cancers: [Oesophageal cancer](https://onco.cc/cancers/esophageal/)
- companies: [Japan Clinical Oncology Group (JCOG)](https://onco.cc/companies/jcog/)
- trials: [CROSS](https://onco.cc/trials/cross/)
- ideas: [A permanently funded international network for randomised cancer surgery trials](https://onco.cc/ideas/idea-fund-surgical-trials-network/)
- institutions: [Keio University Hospital](https://onco.cc/institutions/keio-university-hospital/)

---
JSON: https://onco.cc/api/v1/entities/kitagawa-yuko.json